Induced sputum SP-D levels in COPD patients receiving inhaled corticosteroid treatment were significantly higher than in patients who were not receiving inhaler corticosteroid treatment (p = 0.005). This evidence concerns the gene SFTPD and chronic obstructive pulmonary disease.